Page 1

November 22 , 2021 KHIRON LIFE SCIENCES CORP Khiron Reports Q3 Results - Revenue Increased 83 % YoY , 26 % QOQ • Q3 2021 revenue increased 83 % YoY to $ 3.5 million compared to the previous year • Gross profit before changes in FV in Q3 2021 increased 62 % sequentially to $ 1.7 million Medical cannabis revenues increased 46 % sequentially to $ 1.2 million • Continued strong gross margins for medical cannabis segment at 89 % TORONTO , Nov. 22 , 2021 / CNW / - Khiron Life Sciences Corp. ( " Khiron " or the " Company " ) ( TSXV : KHRN ) ( OTCQX : KHRNF ) ( Frankfurt : A2JMZC ) , a vertically integrated cannabis leader with core operations in Latin America and Europe , today announces its financial results for the quarter ended September 30 , 2021. These filings are available for review on the Company's SEDAR profile at www.sedar.com . All financial information in this press release is reported in Canadian dollars , unless otherwise indicated . KHIRON LIFE SCIENCES CORP Third Quarter 2021 Highlights • Medical cannabis revenue of $ 1.2 million , represents 34 % of total revenue • Europe represents 31 % of medical cannabis revenue • Increased gross margin for clinic services segment of 26 % , compared to 12 % in Q3